Anal Neoplasm

2 clinical trials · Condition

Record	Firm	Date
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors (NCT05551117)	MacroGenics	2023-06-13
VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 (NCT03499795)	Inovio Pharmaceuticals	2018-05-15

Every clearance here is in the API, with alerts when new ones post.